This compound is a building block used in peptide synthesis, featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and an alpha-aminoisobutyric acid (Aib) residue. It is commonly employed as a pharmaceutical intermediate for the preparation of modified peptides in research and manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 94744-50-0
O-(tert-Butyl)-N-((9H-fluoren-9-ylmethoxy)carbonyl)-L-serine
peptide synthesis building block
N-(9-fluorenylmethoxycarbonyl)-d-alanine
peptide synthesis building block
N-Methyl-L-valine
peptide synthesis building block
ALANINE METHYL ESTER HYDROCHLORIDE
peptide synthesis building block
2-Amino-N-(2-aminoethyl)thiazole-4-carboxamide
pharmaceutical intermediate
Celecoxib N-des(benzenesulfonamide)
Pharmaceutical intermediate impurity
Ethyl 4-bromo-3-(ethoxymethyl)benzoate
Pharmaceutical intermediate
((2R,3R,4R,5R)-5-(2-Amino-7-methyl-6-oxo-3,6-dihydro-9H-purin-7-ium-9-yl)-3-hydroxy-4-methoxytetrahydrofuran-2-yl)methyl hydrogen phosphate
RNA modification intermediate
2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methylpropanoic acid
HOZZVEPRYYCBTO-UHFFFAOYSA-N
CC(C)(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13